Clinical Trial

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

Study acronym: RAMP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 10, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-24.
Trial Details
NCT Number NCT06802861
Lead Sponsor University of Tennessee Graduate School of Medicine
Conditions Preeclampsia, Preeclampsia (PE), Preeclampsia (PE) Risk, Obesity and Obesity-related Medical Conditions, Pregnancy, Pregnancy Complications, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy +1 more
Enrollment 50 participants
Start Date 2025-01-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-10